AC Immune Ltd (ACIU) — Capital Reinvestment Ratio
Latest as of December 2024:
0.02x
AC Immune Ltd (ACIU) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.93 Million) in capital expenditures ($90.00K). See cash generation quality of AC Immune Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$5.93 Million
USD
Capital Expenditures
$90.00K
USD
Data as of
Dec 2024
Most recent filing
AC Immune Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks AC Immune Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for AC Immune Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for AC Immune Ltd from 2015 to 2024. For live market cap and broader valuation context, see market cap of AC Immune Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $65.84 Million | $576.00K | ▼ -74.4% |
| 2019 | 0.03x | $55.22 Million | $1.89 Million | ▲ +516.7% |
| 2015 | 0.01x | $44.08 Million | $244.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow